Roche logo
Roche
RHHVF | OTC
Chart Builder DCF Calculator
$483.84
-$3.66 (-0.75%)
At close: Nov 16, 2026, 3:37 PM ET
$489.00
+$5.16 (+1.07%)
Pre-market: Nov 16, 2026, 9:35 AM ET

Roche Company Profile

Company profile explained

Company Profile

Roche Holding AG operates as a global healthcare leader, specializing in both pharmaceuticals and diagnostics. The company's reach extends across key markets like Switzerland, Germany, and the United States, in addition to its broader international footprint. Its extensive pharmaceutical division develops and offers treatments for a diverse range of conditions. These therapeutic areas encompass critical fields such as oncology (cancer), neuroscience, infectious diseases, immunology, hemophilia, ophthalmology (eye care), dermatology (skin conditions), respiratory illnesses, anemia, inflammatory and autoimmune disorders, and transplantation. Beyond medicinal products, Roche is also a prominent supplier of in vitro diagnostic tests. These tests are vital for identifying numerous diseases, including various cancers, cardiovascular conditions, diabetes, COVID-19, hepatitis, and human papillomavirus (HPV). Complementing its testing services, the company provides the essential diagnostic instruments and chemical reagents necessary for these procedures. Demonstrating its commitment to innovation, Roche has established a research partnership with Synlogic, Inc. This collaboration aims to discover a novel synthetic biotic designed specifically for the treatment of inflammatory bowel disease (IBD). Tracing its origins back to its founding in 1896, Roche Holding AG is headquartered in Basel, Switzerland.

Key Executives

Name Position
Thomas Schinecker Group Chief Executive Officer
Alan Hippe Chief Financial Officer
Maria Cristina A. Wilbur Chief People Officer
Boris L. Zaitra Head of Corporate Business Development
Bruno Eschli Head of Investor Relations
Claudia Bockstiegel General Counsel
Nicolas Dunant Head of Group Media Relations
Nina Schwab-Hautzinger Head of Group Communications
Severin Schwan Executive Chairman
Wafaa Mamilli Chief Digital & Technology Officer
Roche
Roche logo
Country Switzerland
IPO Date Feb 13, 2009
Industry Drug Manufacturers - General
Sector Healthcare
Employees 103,249
CEO Thomas Schinecker

Contact Details

Grenzacherstrasse 124 Basel 4070 Switzerland

Stock Details

Ticker Symbol RHHVF
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number CH1499059983
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.